- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +87 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- Universitaet Leipzig Leipzig, Germany
Clinical trial condition
Sezary Syndrome
Explore clinical trials studying Sezary Syndrome. Study availability and eligibility vary by location and protocol.
262 public trials
17 recruiting studies
Sezary Syndrome trial results
Completed
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
NCT01134341
- Conditions
- Cutaneous T-Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT00036790
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +126 more
- Locations
-
- Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
- University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States
NCT01326702
- Conditions
- Adult B Acute Lymphoblastic Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult Solid Neoplasm, +88 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Completed
Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma
NCT00049712
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
- Locations
-
- University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States
Completed
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
NCT02652715
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, +76 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00856388
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, +179 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT00436618
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- Mayo Clinic - Jacksonville Jacksonville, Florida, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
NCT01529827
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +179 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT02243579
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +19 more
- Locations
-
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- Yale University New Haven, Connecticut, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States